BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 15740097)

  • 1. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering non-natural inhibitor sensitivity in protein tyrosine phosphatase H1.
    Blair ER; Hoffman HE; Bishop AC
    Bioorg Med Chem; 2006 Jan; 14(2):464-71. PubMed ID: 16182535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
    Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
    Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
    Bishop AC; Blair ER
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
    Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
    Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
    Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
    Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
    Schmidt MF; Groves MR; Rademann J
    Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered inhibitor sensitivity in the WPD loop of a protein tyrosine phosphatase.
    Zhang XY; Bishop AC
    Biochemistry; 2008 Apr; 47(15):4491-500. PubMed ID: 18358001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
    Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
    Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
    Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
    Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of catalytically inactive mutants of protein tyrosine phosphatases (PTPs) in a phosphopeptide microarray.
    Sun H; Tan LP; Gao L; Yao SQ
    Chem Commun (Camb); 2009 Feb; (6):677-9. PubMed ID: 19322419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.